AHF Welcomes U.S. Reps. Doggett and DeLauro’s Inquiry re: Gilead’s Use of Public Funds Developing COVID-19 Treatment

Representatives Lloyd Doggett (D-TX) and Rosa DeLauro (D-CT) for their demand for an accounting of how Gilead Sciences has used public funds to make private profit off government research for the development of remdesivir.